Mesoblast (MESO) Invested Capital (2015 - 2025)

Mesoblast has disclosed Invested Capital across 11 years of filings, most recently posting $66.7 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $66.7 million, down 34.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $404.5 million (down 6.34% YoY), and the FY2025 annual result was $121.9 million, up 6.6% from the prior year.
• Invested Capital came in at $66.7 million for Q4 2025 at Mesoblast, down from $121.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $634.6 million in Q2 2021 to a low of $52.7 million in Q1 2021.
• The 5-year median for Invested Capital is $99.0 million (2023), against an average of $161.4 million.
• Across the five-year window, Invested Capital jumped 76.31% in 2021 and tumbled 81.68% in 2023, its largest moves.
• Mesoblast's Invested Capital stood at $86.5 million in 2021, then advanced by 12.07% to $97.0 million in 2022, then advanced by 10.56% to $107.2 million in 2023, then slipped by 5.37% to $101.5 million in 2024, then plunged by 34.23% to $66.7 million in 2025.
• The last three Invested Capital figures came in at $66.7 million (Q4 2025), $121.9 million (Q2 2025), and $101.5 million (Q4 2024), per Business Quant data.